Eledon Pharmaceuticals (ELDN) Financials

$2.82

$-0.11 (-3.75%)

As on 09-Sep-2026 16:14EDT

Market cap

$245 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

7.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	0.12
Cost of Revenue	--	--	0.36	0.37	0.37	0.20
Gross Profit	--	--	-0.36	-0.37	-0.37	0.12
Operating Expenses	84.60	83.25	70.58	42.63	88.43	36.87
Operating Profit (EBIT)	-84.60	-83.25	-70.58	-43.00	-88.43	-36.87
Other Income	--	--	--	--	--	--
Profit before Tax	-98.53	-45.58	-35.75	-40.33	-87.97	-36.86
Provision for Tax	0.04	0.04	0.43	--	-0.46	-2.35
Profit after Tax (Net Income)	-98.56	-45.62	-36.18	-40.33	-87.97	-34.51
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-34.51

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	72.03	81.09	118.14	83.42	84.18	164.00
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	42.27	69.58	47.69	38.58	2.14	2.15
Current Liabilities	11.79	18.34	11.58	3.90	6.48	4.40
Total Liabilities	137.88	169.01	177.41	125.89	92.79	170.55

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	33.00	33.32	33.68	69.77	33.28	82.20
Current Assets	93.09	135.69	143.73	56.13	59.52	88.35
Total Assets	137.88	169.01	177.41	125.89	92.79	170.55
Total Debt*	0.47	0.64	0.95	0.38	0.75	0.77
Net Current Assets	81.30	117.34	132.15	52.23	53.04	83.95

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-62.34	-47.27	-39.53	-28.42	-28.91
Cash Flow from Investing Activities	--	10.79	-70.31	--	--	--
Cash from Financing Activities	--	53.81	133.52	33.02	33.02	-0.45
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.99	-0.60	-0.61	-1.67	-6.39	-2.41
Cash EPS ($)	--	-0.60	-0.60	-1.65	-6.36	-2.40
Adjusted Book Value ($)	--	1.07	1.98	3.45	6.11	11.46
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.83	-0.79	-1.63	-2.06	-2.02
Free Cash Flow per Share ($)	--	-0.83	-0.79	-1.63	-2.06	-2.02

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-45.43	-35.67	-47.80	-70.46	-19.41
ROE (%)	-128.74	-45.79	-35.90	-48.12	-70.89	-19.46
ROA (%)	-66.48	-26.34	-23.86	-36.88	-66.81	-18.77
EBIT Margin (%)	--	--	--	--	--	-30,722.50
Net Margin (%)	--	--	--	--	--	-28,755.00
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	-1.00	--
EBIT Growth (%)	-225.05	-27.49	16.85	-8.09	-7.90	-127.81
Net Profit Growth (%)	-773.09	-26.07	10.27	54.16	-154.93	-51.27
EPS Growth (%)	-340.59	0.00	0.64	0.74	-1.65	-0.60
Book Value Growth (%)	-53.87	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.50	-6.81	-1.08	-0.36	-1.83
Price / Book Value	7.41	1.40	2.09	0.52	0.37	0.38
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.84	0.42	-3.03	0.17	0.62	0.57
Close Price ($)	3.94	1.51	4.12	1.80	2.28	4.41
High Price ($)	4.60	4.98	5.54	3.70	5.14	22.91
Low Price ($)	1.35	1.35	1.52	1.07	2.03	3.81
Market Cap ($ Cr)	245.41	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.01	0.00	0.01	0.00
Short term debt to equity ratio	0.01	0.00	0.00	0.00	0.00	0.00
Current Ratio	7.90	7.40	12.42	14.41	9.19	20.07
Quick Ratio	7.90	--	--	--	--	--
Interest Coverage	--	--	--	--	-86.10	-182.51

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	0.00
Receivable days	--	--	--	--	--	334.81
Inventory Days	--	--	--	--	--	2,410.65
Payable days	--	--	3,459.19	1,546.45	1,964.81	2,977.26
Cash Conversion Cycle	--	--	--	--	--	-231.79

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.